News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 30 abr 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
News 04 dez 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
News 23 abr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
Branchenreport 20 fev 2024 Fintech in Kenia Als Teil zwei der regionalen Fintech-Serie beleuchtet dieser Bericht nach Südafrika nun den kenianische Fintech-Sektor. Die von Innovation, einer...
Rapport sectoriel 19 fev 2024 Le secteur des Fintech au Kenya Après un premier rapport sur les fintech en Afrique du Sud, voici un nouveau rapport qui met en lumière le paysage des fintech au Kenya. Caractér...
Branchenreport 23 jan 2024 Globale Geschäftsmöglichkeiten für Schweizer Fintechs Dieser umfassende Bericht rüstet Schweizer Fintechs mit dem Wissen und den Erkenntnissen aus, die sie benötigen, um sich in der sich stets wandel...
Rapport sectoriel 23 jan 2024 Opportunités fintech à l’international pour sociétés suisses Ce rapport complet du think tank suisse e.Foresight fournit aux fintechs suisses les informations dont elles ont besoin pour naviguer dans le pay...
News 17 abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Rapporti settoriali 19 fev 2024 Il settore fintech in Kenya Dopo un primo rapporto sul fintech in Sudafrica, ecco un nuovo rapporto che evidenzia il panorama fintech in Kenya. Caratterizzato da un forte sp...
News 04 abr 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
Rapporti settoriali 23 jan 2024 Opportunità fintech internazionali per le aziende svizzere Questo rapporto completo del think tank svizzero e.Foresight fornisce alle PMI fintech svizzere le informazioni necessarie per orientarsi nel pan...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 abr 2024 10:15–12:10 Zürich Suíça
News 26 mar 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...